ﻻ يوجد ملخص باللغة العربية
Large amounts of unlabelled data are commonplace for many applications in computational pathology, whereas labelled data is often expensive, both in time and cost, to acquire. We investigate the performance of unsupervised and supervised deep learning methods when few labelled data are available. Three methods are compared: clustering autoencoder latent vectors (unsupervised), a single layer classifier combined with a pre-trained autoencoder (semi-supervised), and a supervised CNN. We apply these methods on hematoxylin and eosin (H&E) stained prostatectomy images to classify tumour versus non-tumour tissue. Results show that semi-/unsupervised methods have an advantage over supervised learning when few labels are available. Additionally, we show that incorporating immunohistochemistry (IHC) stained data provides an increase in performance over only using H&E.
Prostate cancer is one of the most common forms of cancer and the third leading cause of cancer death in North America. As an integrated part of computer-aided detection (CAD) tools, diffusion-weighted magnetic resonance imaging (DWI) has been intens
Identifying prostate cancer patients that are harboring aggressive forms of prostate cancer remains a significant clinical challenge. To shed light on this problem, we develop an approach based on multispectral deep-ultraviolet (UV) microscopy that p
Ultrasound image diagnosis of breast tumors has been widely used in recent years. However, there are some problems of it, for instance, poor quality, intense noise and uneven echo distribution, which has created a huge obstacle to diagnosis. To overc
Breast cancer is the malignant tumor that causes the highest number of cancer deaths in females. Digital mammograms (DM or 2D mammogram) and digital breast tomosynthesis (DBT or 3D mammogram) are the two types of mammography imagery that are used in
Accurate delineation of the intraprostatic gross tumour volume (GTV) is a prerequisite for treatment approaches in patients with primary prostate cancer (PCa). Prostate-specific membrane antigen positron emission tomography (PSMA-PET) may outperform